WAINUA (eplontersen) injection

WAINUA is a prescription medicine used to treat polyneuropathy. FDA approved eplontersen (brand name WAINUA) is not (yet) registered or available in India but on request Indian patient can buy WAINUA at the lowest price.

WAINUA-eplontersen-Price-Delhi-India
WAINUA (eplontersen) injection

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

WAINUA (eplontersen) injection

Eplontersen, is a medication used for the treatment of transthyretin-mediated amyloidosis.

WAINUA is a transthyretin-directed antisense oligonucleotide indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults

Eplontersen, sold under the brand name Wainua, is a medication used for the treatment of transthyretin-mediated amyloidosis. It is a transthyretin-directed antisense oligonucleotide. It was developed to treat hereditary transthyretin amyloidosis.

Eplontersen was approved for medical use in the United States in December 2023 and in the UK in October 2024.

WAINUA™ (eplontersen) injection, for subcutaneous use Initial U.S. Approval: 2023
—————-
Current Indication: Treat of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.
—————-
Marketed By: AstraZeneca
—————-
Approval Date: : 2023
—————-
Active ingredient: eplontersen
—————-

Injection: 45 mg/0.8 mL in a single-dose autoinjector.

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.